SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001012477-17-000028
Filing Date
2017-05-01
Accepted
2017-05-01 15:58:10
Documents
6
Period of Report
2017-06-28
Effectiveness Date
2017-05-01

Document Format Files

Seq Description Document Type Size
1 DEF 14A def14a-avdl2017proxystatem.htm DEF 14A 1151947
2 avadel2017proxys_image1.jpg GRAPHIC 18066
3 proxycardpage1a.jpg GRAPHIC 306962
4 proxycardpage2a.jpg GRAPHIC 235759
5 votinginstructioncardpage1.jpg GRAPHIC 205083
6 votinginstructioncardpage2.jpg GRAPHIC 211767
  Complete submission text file 0001012477-17-000028.txt   2499588
Mailing Address 16640 CHESTERFIELD GROVE ROAD SUITE 200 CHESTERFIELD MO 63005
Business Address BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK BALLYCOOLIN DUBLIN L2 15 636-449-1830
AVADEL PHARMACEUTICALS PLC (Filer) CIK: 0001012477 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37977 | Film No.: 17800600
SIC: 2834 Pharmaceutical Preparations